STA - Neoplastine® Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT).
Published March 21, 2018 · Recall initiated: October 25, 2017
Summary
FDA records medical device Class II recall Z-1069-2018, published March 21, 2018 and initiated October 25, 2017. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Lot: Lot: 250041RX (Exp: 2018-02) Lot: 250077 (Exp: 2018-02) Lot: 250246RU (Exp: 2018-03) Lot: 251492 (Exp: 2018-09) Lot: 251308 (Exp: 2018-10) Lot: 251626 (Exp: 20 19-01) Lot: 251730 (Exp: 2019-02) Lot: 251772 (Exp: 2019-02). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diagnostica Stago, Inc.
- Distributor
- Nationally
- Lot
- Lot: 250041RX (Exp: 2018-02) Lot: 250077 (Exp: 2018-02) Lot: 250246RU (Exp: 2018-03) Lot: 251492 (Exp: 2018-09) Lot: 251308 (Exp: 2018-10) Lot: 251626 (Exp: 20 19-01) Lot: 251730 (Exp: 2019-02) Lot: 251772 (Exp: 2019-02)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASTA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitativeSeptember 9, 2026
- FDASTA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use withSeptember 3, 2025
- FDADiagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombinSeptember 19, 2018
- FDANeoplastine® Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDANeoplastine® Cl Plus ¿ (ref. 00375) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDAPORT-A-CATH II PS/Titan, Tray PAC II. Labeled as: a. VEN LP, PU, 2.6MM, UL, 8.5FR/INTRO (1/EA); b. DL, LP, PU,March 21, 2018
Questions about this recall
Was STA - Neoplastine® Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT). recalled?
Yes. FDA published recall Z-1069-2018 on March 21, 2018. Reported hazard: Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).
What should I do if I have this product?
Voluntary: Firm initiated · Letter